Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis

Bloemendaal, F.M.; Levin, A.D.; Wildenberg, M.E.; Koelink, P.J.; McRae, B.L.; Salfeld, J.; ... ; Brink, G.R. van den (2017)

Article / Letter to editor

• Crohn's Disease
• Fc gamma Receptor
• Drug Modification
• Mouse Model

• All authors: Bloemendaal, F.M.; Levin, A.D.; Wildenberg, M.E.; Koelink, P.J.; McRae, B.L.; Salfeld, J.; Lum, J.; Kolfschoten, M.V.; Claassens, J.W.; Visser, R.; Bentlage, A.; D'Haens, G.R.A.M.; Verbeek, J.S.; Vidarsson, G.; Brink, G.R. van den
• Date: 2017-11-30
• Journal: Gastroenterology
• Volume: 153
• Issue: 5
• Pages: 1351 - +
• DOI: doi:10.1053/j.gastro.2017.07.021